CN103619405A - 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 - Google Patents
用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 Download PDFInfo
- Publication number
- CN103619405A CN103619405A CN201280031279.9A CN201280031279A CN103619405A CN 103619405 A CN103619405 A CN 103619405A CN 201280031279 A CN201280031279 A CN 201280031279A CN 103619405 A CN103619405 A CN 103619405A
- Authority
- CN
- China
- Prior art keywords
- pulse
- hours
- superthreshold
- disease
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Landscapes
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本文描述了用于施加足以治疗慢性炎症的极低占空比刺激的方法和系统。尤其是,本文描述了足以导致对促炎细胞因子和/或慢性炎症的影响的持久(例如,>4小时、大于12小时、大于24小时、大于48小时)抑制的电刺激的单个超阈值脉冲。这些方法和设备对治疗炎症性肠病(IBD)尤其感兴趣。
Description
相关申请的交叉引用
本申请要求于2011年5月9日提交的美国临时申请61/484,112的利益,在此通过引用将其整体结合。本专利申请可以涉及下列专利和待决的专利申请中的任一项:于2009年5月1日提交并且题为“VAGUS NERVE STIMULATION ELECTRODES AND METHODSOF USE”的美国申请12/434,462;2009年11月17日提交并且题为“DEVICES AND METHODS FOR OPTIMIZING ELECTRODEPLACEMENT FOR ANTI-INFLAMMATORY STIMULATION”的美国申请12/620,413;2010年9月1日提交并且题为“PRESCRIPTION PADFOR TREATMENT OF INFLAMMATORY DISORDERS”的美国申请12/874,171;2010年11月1日提交并且题为“MODULATION OF THECHOLINERGIC ANTI-INFLAMMATORY PATHWAY TO TREATPAIN OR ADDICTION”的美国申请12/917,197;2010年12月23日提交并且题为“NEURAL STIMULATION DEVICES AND SYSTEMSFOR TREATMENT OF CHRONIC INFLAMMATION”的美国申请12/978,250;以及2010年6月9日提交并且题为“NERVE CUFF WITHPOCKET FOR LEADLESS STIMULATOR”的美国申请12/797,452。
通过引用的结合
本说明书中提及的所有出版物和专利申请通过引用整体结合于此,其程度如同每个单独的出版物或专利申请被特别地和单独地指示为通过引用结合。
技术领域
本发明总体上涉及用于使用极低占空比刺激来治疗包括慢性炎症和炎症性疾病(disorder)在内的疾病的系统和设备。尤其是,本文描述了用于治疗诸如肠道炎症性疾病之类的疾病的系统、设备和方法。本文总体上还描述了适于通过用于调整炎症性反应的极低占空比刺激对迷走神经(vagus nerve)进行电刺激以(经由烟碱性胆碱能抗炎通路(nicotinic cholinergic anti-inflammatory pathway))治疗慢性炎症的方法以及包括可植入微刺激器在内的设备。
背景技术
在文献中已经描述了神经胆碱能抗炎通路(CAP或NCAP)的电刺激,其开始于Kevin Tracey的开创性工作(例如,见Tracey KJ的“Physiology and immunology of the cholinergic antiinflammatorypathway”,The Journal of clinical investigation2007:117(2):289–96),他首次确认了胆碱能抗炎通路并且描述了迷走神经刺激与通过抑制细胞因子的产生的炎症的抑制之间的联系,从那以后,研究继续进行以探索CAP的刺激与炎症性疾病的调整之间的关系。通常的刺激参数已经包括了通过一阵脉冲(例如,在10Hz到1GHz之间持续30秒钟到20分钟)的刺激,具有在较高频率处看的效果的略微提高(例如,见Huston等人的US2009/0143831)。
尽管该工作已经暗示慢性炎症可以通过可植入刺激器成功地治疗,但是这样的长期地可植入和可用的刺激器的设计和实施已经证明是难懂的,部分地是由于能够真正长期使用的设备将面对的功率要求。
已经针对各种病症和疾病的治疗开发了可植入电刺激设备。例如,可植入心脏复律除颤器(ICD)已经用于治疗各种心脏疾病。脊髓刺激器(SCS)或脊柱刺激器(DCS)已经用于治疗包括背部手术失败综合征、复合性局部疼痛综合征和周围神经病在内的慢性疼痛疾病。周围神经刺激(PNS)系统已经用于治疗慢性疼痛综合征以及其他疾病和疾病。功能电刺激(FES)系统已经被用于在脊髓受伤患者中将某一功能恢复到否则瘫痪的四肢。
最近,已经开发了可植入的迷走神经刺激,包括用于治疗炎症的迷走神经刺激器。这样的植入物通常需要电极和电源。尺寸和用途限制的参数可以通常是功率要求,其要么要求持久的(并且因此通常大的)电池,要么要求充电电路和充电设备所增加的复杂化。
例如,通常的可植入电刺激系统可以包括引线上的一个或多个可编程电极,该可编程电极连接到可植入脉冲发生器(IPG),该可植入脉冲发生器包含电源和刺激电路。甚至相对小的可植入神经刺激器技术(即,具有附接到刺激器的本体的整体电极的微刺激器)可能也有这些缺点中的一些缺点,因为当前开发的无引线设备往往比期望的更大和更重,使得难以稳定地将这些设备相对于神经定位在合适的位置。
本文描述了令人惊讶的结果,即炎症的持久的、稳健的抑制可以通过在施加到迷走神经的单个(或非常少的)超阈值的电脉冲来实现。考虑到尽管施加最小功率却获得格外稳健的效果,该发现尤其令人惊讶,特别是与以高得多的施加的能量显示效果的公布的数据相比。这些发现支持用于治疗慢性炎症的各种极低功率的设备、系统和方法。尤其是,描述了用于治疗包括肠道的炎症性疾病(例如,肠易激症或IBD)在内的炎症性疾病的设备和方法,包括微刺激器以及基于所确认的显著低的功率要求使用微刺激器的方法。
发明内容
本文描述了用于迷走神经的格外低占空比刺激的设备、系统和方法。格外低、极低、超级低或超低占空比一般指的是使用每个时间周期的少数电脉冲和低刺激强度两者来提供刺激以使得占空比的功率要求非常低的占空比。下面是格外低、极低、超级低或超低占空比的各种实施例的示例。在一些实施例中,每4到48小时(以4小时为增量),电脉冲的数目可以介于1和5之间(以1个脉冲为增量)。在一些实施例中,刺激强度可以处于能够通过迷走神经影响所期望的生理反应的超阈值水平。在一些实施例中,超阈值水平介于大约100μA和5000μA之间,或者介于大约100μA和4000μA之间,或者介于大约100μA和3000μA之间,或者介于大约100μA和2000μA之间。在一些实施例中,超阈值水平小于大约2000μA、3000μA、4000μA或5000μA。
在一些实施例中,占空比是每4小时1个超阈值脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每4小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约3000μA。
在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
在一些实施例中,提供用于治疗患者的慢性炎症和/或炎症性疾病的系统。该系统包括可植入微刺激器,被配置为向迷走神经施加低占空比刺激,其中低占空比刺激每4小时仅提供单个超阈值脉冲;以及控制器,被配置为设置用于微刺激器的剂量,其中该剂量包括被至少4小时的关断周期跟随的单个超阈值脉冲。在一些实施例中,关断周期是至少24小时,或者是至少48小时,或者介于大约4到48小时之间,或者介于大约12到48小时之间,或者介于大约24到48小时之间。在一些实施例中,单个超阈值脉冲具有小于5mA、小于3mA或者小于2mA的脉冲振幅。在一些实施例中,单个超阈值脉冲是双相的。在一些实施例中,慢性炎症是肠道炎症。在一些实施例中,慢性炎症是炎症性肠病。在一些实施例中,慢性炎症是克罗恩病(Crohn’sdisease)。
在一些实施例中,提供一种治疗患者的慢性炎症和/或炎症性疾病的方法。该方法包括:植入微刺激器;以及向迷走神经仅施加来自微刺激器的单个超阈值刺激脉冲,该单个超阈值刺激脉冲被至少4小时的关断时间跟随。在一些实施例中,关断时间是至少24小时,至少48小时,或者介于大约4到48小时之间,或者介于大约12到48小时之间,或者介于大约24到48小时之间。在一些实施例中,单个超阈值刺激脉冲具有小于5mA、小于3mA或者小于2mA的脉冲振幅。在一些实施例中,单个超阈值刺激脉冲是双相的。在一些实施例中,慢性炎症是肠道炎症。在一些实施例中,慢性炎症是炎症性肠病。在一些实施例中,慢性炎症是克罗恩病。
如本文所描述的可以被治疗的各种类型的炎症性疾病包括各种疾病状态,包括诸如枯草热、动脉粥样硬化、关节炎(类风湿、滑囊炎、痛风性关节炎、风湿性多肌痛等)、哮喘、自身免疫疾病、慢性炎症、慢性前列腺炎、肾小球肾炎、肾炎、炎症性肠病、盆腔炎性疾病、再灌注损伤、移植排斥、血管炎、心肌炎、结肠炎等疾病。
可以使用本发明治疗的炎症性疾病的非限制性示例包括:阑尾炎、消化性溃疡、胃溃疡、十二指肠溃疡、腹膜炎、胰腺炎、溃疡性结肠炎、伪膜性肠炎、急性结肠炎、缺血性结肠炎、憩室炎、会厌炎、失弛缓症、胆管炎、胆囊炎、肝炎、克罗恩病、肠炎、惠普尔病、过敏、过敏性休克、免疫复合物病、器官缺血、再灌注损伤、器官坏死、枯草热、脓毒症、败血症、内毒素性休克、恶病质、高热、嗜酸性肉芽肿、肉芽肿病、结节病、脓毒性流产、附睾炎、阴道炎、前列腺炎、尿道炎、支气管炎、肺气肿、鼻炎、肺炎、火山矽肺病(pneumoultramicroscopic silicovolcanoconiosis)、牙槽炎(alvealitis)、支气管炎、咽炎、胸膜炎、鼻窦炎、流感、呼吸道合胞病毒感染、HIV感染、乙型肝炎病毒感染、丙型肝炎病毒感染、疱疹病毒感染播散菌血症、登革热、念珠菌病、疟疾、丝虫病、变形虫病、包虫囊肿、烧伤、皮炎、皮肌炎、晒伤、荨麻疹、疣、风团、血管炎(vasulitis)、脉管炎、心内膜炎、动脉炎、动脉粥样硬化、血栓性静脉炎、心包炎、心肌炎、心肌缺血、结节性动脉周炎、风湿热、阿尔茨海默氏病、腹部疾病、充血性心脏衰竭、成人呼吸窘迫综合征、脑膜炎、脑炎、多发性硬化、脑梗塞、脑栓塞、格林-巴利综合征、神经炎、神经痛、脊髓损伤、瘫痪、葡萄膜炎、关节炎、关节痛、骨髓炎、筋膜炎、佩吉特氏病、痛风、牙周病、类风湿性关节炎、滑膜炎、重症肌无力、甲状腺炎、系统性红斑狼疮、古德帕斯彻氏综合征、白塞氏综合征、同种异体移植物排斥、移植物抗宿主病、一型糖尿病、二型糖尿病、强直性脊柱炎、伯杰氏病、赖特综合征、何杰金氏病、肠梗阻、高血压、肠易激综合征、心肌梗死、失眠、焦虑以及支架血栓。
附图说明
本发明的新特征与随后的权利要求中的特殊性一起被提出。通过参考下面提出说明性实施例(其中利用了本发明的原理)的详细描述以及附图,将获得本发明的特征和优点的更好的理解,其中:
图1是单个刺激波形的图形;
图2是将来自单个刺激脉冲的对TNF水平的影响与来自多达3000个脉冲的影响进行比较的曲线图;
图3是图示刺激后24小时来自单个刺激脉冲的对TNF水平的影响的曲线图;
图4是图示刺激后3小时和24小时来自单个刺激脉冲的对TNF水平的影响的曲线图;
图5是图示来自单个刺激脉冲的对IBD的大鼠模型中的损伤区域的影响的曲线图;以及
图6是图示来自单个刺激脉冲的对IBD的大鼠模型中的损伤区域的长期影响的曲线图。
具体实施方式
一般而言,本文描述了阐述用于治疗疾病的迷走神经的格外低占空比刺激的系统、方法和设备。尤其是,本文描述了阐述用于在哺乳动物模型中减少或防止炎症和炎症的影响的迷走神经的格外低占空比刺激的系统、方法和设备。格外低、极低、超级低或超低占空比一般指的是使用每个时间周期的少数电脉冲和低刺激强度两者来提供刺激以使得占空比的功率要求非常低的占空比。本文所描述的方法应用可以被用来显著减少炎症和/或炎症的影响的各种刺激方案。可以变化的刺激参数包括脉冲形状(例如,正弦的、方的、双相的、单相的等)、刺激的持续时间、导通时间、关断时间、脉间间隔,等等。本文检查的一个关键因素是超阈值脉冲的数目。如本文所示,即使当与多个刺激比较时,使用甚至单个超阈值刺激的迷走神经的刺激导致显著的和持久的影响。该影响当使用针对IBD的啮齿动物模型进行检查时尤为深刻。
下面是格外低、极低、超级低或超低占空比的各种实施例的示例。在一些实施例中,每4到48小时(以4小时为增量),电脉冲的数目可以介于1和5之间(以1个脉冲为增量)。在一些实施例中,刺激强度可以处于能够通过迷走神经影响所期望的生理反应的超阈值水平。在一些实施例中,超阈值水平介于大约100μA和5000μA之间,或者介于大约100μA和4000μA之间,或者介于大约100μA和3000μA之间,或者介于大约100μA和2000μA之间。在一些实施例中,超阈值水平小于大约2000μA、3000μA、4000μA或5000μA。
在一些实施例中,占空比是每4小时1个超阈值脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每4小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每12小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每24小时1个脉冲,且脉冲振幅小于约3000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约2000μA。在一些实施例中,占空比是每48小时1个脉冲,且脉冲振幅小于约3000μA。
本文所描述的示例使用被开发以用于驱动迷走神经刺激的刺激器和刺激控制包。在一些示例中,该刺激由软件包控制,该软件包被配置为在微处理器(例如个人计算机)上运行并且控制仿真器/刺激器(其可以称为ITE或集成终端仿真器)的输出。因此,本文所描述的系统可以包括可以是用于控制刺激的施加的软件、固件和/或硬件的逻辑(例如控制逻辑)。例如,在一些变化形式中,控制刺激和数据采集的参数可以包括:(1)包括阴极和阳极的选择的刺激电极对;(2)以1Hz为增量的频率;(3)脉冲宽度(PW):20-2,000μS(以1μS为增量);(4)脉冲振幅(PA):±0-5,000μA(以3μA为增量);以及(5)波形的A相和B相之间的脉间间隔(IPI):20-2,000μS(以1μS为增量)。
除了以上提供的示例性参数,在一些实施例中,PW可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
例如,图1上所示的示例性波形是双相的(电荷平衡的)波形100,其包括通过脉间间隔104(IPI)被隔开的两个对称的脉冲宽度102(PW)。脉冲宽度102具有脉冲振幅106(PA),其对于双相刺激的第一相108(A相)和第二相110(B相)也是对称的,且A相中是负脉冲振幅,而B相中是正振幅。可以使用其它脉冲波形。在一些实施例中,脉冲波形可以是非双相的并且/或者可以具有非对称的脉冲宽度和/或非对称的脉冲振幅。
刺激器可以在一对电极上生成脉冲串。这些脉冲可以使用双极电流源来生成,并且可以在两个电极输出上使用>1μF的陶瓷电容器来容性地隔离,恒流输出电压可以被设置为高达±18.8伏。
本文所描述的不同实验示例显示,迷走神经的合适的NCAP刺激可以用来限制或消除肠道炎症的影响,尤其在结肠炎的大鼠模型和克罗恩病的大鼠模型中。基于该数据,处于上述参数的双相刺激可以成功地治疗肠道炎症。
在一个示例中,小鼠(雄性,BALB/c)被麻醉,并且袖口电极(cuff electrode)(0.3mm ID,0.5mm电极间距离;微探针,Gaithersburg,MD)被置于左颈动脉鞘(包含颈迷走神经)周围且通过缝合来固定。超阈值脉冲(750μA,200μS,10Hz)以各种数目(0,1,10,100,300,600,3000)施加。后来,电极被移除并且关闭钉上的(stapled)伤口。小鼠恢复持续3小时,并且然后使用LPS(5mg/kg;IP)来进行挑战;这些小鼠在LPS之后90分钟牺牲,并且血清TNF通过ELISA测得,以测量对炎症性细胞因子的影响。如图2上所示,甚至单个超阈值刺激导致在治疗之后3小时TNF的显著抑制。因此,影响是持久的,并且来自单个脉冲的3小时处的影响与由多达3000个脉冲产生的影响相当。
进行第二类似实验,以检查单个超阈值脉冲对胆碱能抗炎通路(CAP)的持久影响。小鼠(雄性,BALB/c)被麻醉,并且袖口电极(0.3mm ID,0.5mm电极间距离;微探针,Gaithersburg,MD)被置于左颈动脉鞘(包含颈迷走神经)周围且通过缝合来固定。超阈值脉冲(750μA,200μS,10Hz)以各种数目(0,1,600)施加。后来,电极被移除并且关闭钉上的伤口。小鼠恢复持续24小时,并且然后使用LPS(5mg/kg;IP)来进行挑战;这些小鼠在LPS之后90分钟牺牲,并且血清TNF通过ELISA测得,以测量对炎症性细胞因子的影响。如图3上所示,单个超阈值刺激导致在治疗之后24小时处TNF的显著抑制,其与由600个脉冲产生的影响相当。
图4将以上所描述的两个实验的结果的选择的部分组合,以显示NCAP的单个脉冲刺激以与600个脉冲相同的效力影响刺激后3小时和24小时的可由LPS诱导的TNF的抑制。
在另一示例中,进行实验以确定在针对IBD/克罗恩病的大鼠模型中的损伤区域的单个脉冲抑制的效力。大鼠被麻醉,并且被给予对左颈迷走神经的虚假刺激或者单个超阈值刺激(在750μA、200μS的脉冲宽度、10Hz处的1个脉冲)。IBD通过吲哚美辛(5%碳酸氢钠中的10mg/kg(5mg/mL))的SC注射在刺激后30分钟被诱导。通过使用异氟烷麻醉大鼠并且使用依文思蓝(1%的0.3ml)的四尾部注射来在吲哚美辛注射之后23.5小时完全玷污损伤。大鼠在疾病诱导后24小时经由CO2窒息而牺牲,并且整夜在2%的福尔马林中收割、清洗和固定小肠。对已固定的肠道进行拍照并对照片进行数字化,并且损伤通过盲打分器(blinded scorer)来量化。如图5中图示的,单个超阈值刺激(750μA、200μS的脉冲宽度、10Hz)导致损伤的深刻减少。
考虑到图6中所示的数据,这些结果甚至更为重要,图6图示了在克罗恩病的大鼠模型中迷走神经刺激的“存储器效应”。大鼠被麻醉,并且被给予对左颈迷走神经(1mA、200μS的脉冲宽度、10Hz、60s)的虚假刺激或实际刺激。IBD/克罗恩病通过吲哚美辛(5%碳酸氢钠中的10mg/kg(5mg/mL))的SC注射在刺激之后不同的时间点(见图6)被诱导。通过使用异氟烷麻醉大鼠并且使用依文思蓝(1%的0.3ml)的四尾部注射来在疾病诱导之后23.5小时完全玷污损伤。大鼠在疾病诱导后24小时经由CO2窒息而牺牲,并且整夜在2%的福尔马林中收割、清洗和固定小肠。对已固定的肠道进行拍照并对照片进行数字化,并且损伤通过盲打分器来量化。在该示例中,迷走神经刺激的短暂时期可以导致在减少另外由吲哚美辛的应用所诱导的肠道损伤方面惊人地持久的影响(例如高达48小时)。该数据强烈建议可以极不频繁地提供刺激,具有长的(例如>48小时)、没有所施加的刺激的“寂静”周期。用于治疗IBD的这样的极低占空比刺激可以在可植入系统中尤其有帮助,允许极长的电池寿命,同时具有出乎意料地稳健的疗效。
尽管以上提供的示例描述了用于在大鼠模型中治疗炎症性疾病的方法、系统和设备,但是本文所描述的所有方法、系统和设备可以用于和/或适用于在其他哺乳动物(例如人类)中使用。例如,一种用于使用单个超阈值脉冲和/或格外低占空比刺激方案治疗人类的炎症性疾病的系统和方法可以包括电极(诸如袖口电极),该电极被配置为围绕迷走神经植入并且将电刺激传递到患者的迷走神经。该系统可以进一步包括处理器、用于存储指令的存储器、和/或控制器,该控制器可以包括编程以将包括单个超阈值脉冲方案在内的低占空比刺激方案经由袖口电极传递到迷走神经。可以提供电池来为系统提供功率,并且因为低占空比刺激方案消耗很少的能量,所以电池寿命可以大大延长,允许在电池需要更换或再充电之前系统被完整地植入患者体内很长一段时间。对于植入系统,这提供大的益处,因为其可以减少外科手术的频率,该外科手术可以被要求更换电池。
在该系统中使用的刺激参数可以与以上公开的参数相同或相似。例如,脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
一般而言,这些结果暗示,迷走神经的甚至单个短暂超阈值刺激的应用可以可能通过抑制炎症性细胞因子(诸如TNF)而导致炎症影响的大量减少。这些结果既令人惊讶(考虑到刺激持续长得多的时间的现有技术趋势),又对于设计今后的设备和方法是重要的。尤其是,迷走神经(或炎症性反应的其他部分)的刺激可以被配置为施加极低占空比刺激。如简要地提到的,这将考虑到更小、更轻和更有效率的可植入刺激系统。
如本文所描述的可以被治疗的各种类型的炎症性疾病包括各种疾病状态,包括诸如枯草热、动脉粥样硬化、关节炎(类风湿、滑囊炎、痛风性关节炎、风湿性多肌痛等)、哮喘、自身免疫疾病、慢性炎症、慢性前列腺炎、肾小球肾炎、肾炎、炎症性肠病、盆腔炎性疾病、再灌注损伤、移植排斥、血管炎、心肌炎、结肠炎等疾病。
可以使用本发明治疗的炎症性疾病的非限制性示例包括:阑尾炎、消化性溃疡、胃溃疡、十二指肠溃疡、腹膜炎、胰腺炎、溃疡性结肠炎、伪膜性肠炎、急性结肠炎、缺血性结肠炎、憩室炎、会厌炎、失弛缓症、胆管炎、胆囊炎、肝炎、克罗恩病、肠炎、惠普尔病、过敏、过敏性休克、免疫复合物病、器官缺血、再灌注损伤、器官坏死、枯草热、脓毒症、败血症、内毒素性休克、恶病质、高热、嗜酸性肉芽肿、肉芽肿病、结节病、脓毒性流产、附睾炎、阴道炎、前列腺炎、尿道炎、支气管炎、肺气肿、鼻炎、肺炎、火山矽肺病、牙槽炎、支气管炎、咽炎、胸膜炎、鼻窦炎、流感、呼吸道合胞病毒感染、HIV感染、乙型肝炎病毒感染、丙型肝炎病毒感染、疱疹病毒感染播散菌血症、登革热、念珠菌病、疟疾、丝虫病、变形虫病、包虫囊肿、烧伤、皮炎、皮肌炎、晒伤、荨麻疹、疣、风团、血管炎、脉管炎、心内膜炎、动脉炎、动脉粥样硬化、血栓性静脉炎、心包炎、心肌炎、心肌缺血、结节性动脉周炎、风湿热、阿尔茨海默氏病、腹部疾病、充血性心脏衰竭、成人呼吸窘迫综合征、脑膜炎、脑炎、多发性硬化、脑梗塞、脑栓塞、格林-巴利综合征、神经炎、神经痛、脊髓损伤、瘫痪、葡萄膜炎、关节炎、关节痛、骨髓炎、筋膜炎、佩吉特氏病、痛风、牙周病、类风湿性关节炎、滑膜炎、重症肌无力、甲状腺炎、系统性红斑狼疮、古德帕斯彻氏综合征、白塞氏综合征、同种异体移植物排斥、移植物抗宿主病、一型糖尿病、二型糖尿病、强直性脊柱炎、伯杰氏病、赖特综合征、何杰金氏病、肠梗阻、高血压、肠易激综合征、心肌梗死、失眠、焦虑以及支架血栓。
这些疾病中的任何一种疾病(例如炎症性疾病)可以例如通过在迷走神经周围植入袖口电极并且使用如本文所述的用于治疗的格外低占空比刺激方案来治疗。用于存储指令和/或编程的处理器以及存储器可以用来控制刺激方案。在该系统和方法中使用的刺激参数可以与以上公开的参数相同或相似。例如,单个超阈值脉冲的脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。这些方法中的任何一种方法可以包括确定治疗功效的步骤。例如,这些方法中的任何一种方法可以包括在治疗前和/或期间监视患者的步骤。例如,在治疗炎症性疾病中,可以监视用于炎症的生物标志物,例如细胞因子或其他标志物。在一些变化形式中,监视患者可以包括可视化地评估患者(例如,针对肿胀、体温等)。在一些变化形式中,本文所描述的系统可以包括用于监视患者和/或使用该系统的治疗效果的传感器和/或数据处理子系统。
尽管以上示例和描述主要集中在炎症性疾病上,但是在某一实施例中,本文所描述的系统、设备和方法可以用于治疗非炎症性病症或疾病。例如,本文所描述的系统、设备和方法可以用来通过迷走神经的格外低占空比刺激激活、调节和/或调整去乙酰化酶(sirtuin)的水平。通过迷走神经刺激的去乙酰化酶的调整还在2011年12月27日提交并且题为“MODULATION OF SIRTUINS BY VAGUS NERVESTIMULATION”的美国申请13/338,185中进行了讨论,该申请出于所有目的通过引用全文结合于此。如上,袖口电极可以围绕迷走神经植入,并且用于存储指令和/或编程的处理器和存储器可以用来控制刺激方案。在该系统和方法中使用的刺激参数可以与以上公开的参数相同或相似。例如,单个超阈值脉冲的脉冲振幅可以小于大约5、4、3或2mA。另外,低占空比刺激方案可以在介于大约4到48小时之间或者至少4、12、24或48小时的关断时间之间传递单个超阈值脉冲。在一些实施例中,脉冲宽度可以介于大约100到1000μS之间,或者可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。在一些实施例中,频率可以是大约或小于大约10、20、30、40、50、60、70、80、90或100Hz。在一些实施例中,IPI可以是大约或小于大约100、200、300、400、500、600、700、800、900或1000μS。
如上所述,在一些实施例中,系统、设备和/或方法包括监测刺激对正在治疗的疾病的影响。例如,炎症指示器或疾病指示器或其他指示器可以被监测以评价治疗方案的功效,允许基于该评价调节刺激方案。可以基于该评价调整本文所述参数中的任何一个参数。例如,可以增加或减少脉冲振幅和/或关断时间以优化疗效。可以被监测的指示器的示例包括TNF水平、损伤尺寸、炎症的程度或水平,细胞因子水平、疼痛水平、去乙酰化酶水平,等等。
本文公开的设备和方法的变化和修改对于本领域技术人员而言将很容易是显而易见的。同样地,应当理解的是,前述详细描述和附图是出于清晰和理解的目的而做出,并且并非旨在限制本发明的范围,本发明的范围由附于其的权利要求来限定。在本文所述任何一个实施例中所描述的任何特征可以与其它实施例中的任何实施例的任何其他特征组合而不论是否是优选的。
理解的是,本文所述示例和实施例仅仅是出于说明的目的,并且根据其的各种修改或改变将被建议给本领域技术人员,并且将被包括在本申请的精神和权限以及所附权利要求的范围以内。本文所引用的所有出版物、专利和专利申请出于所有目的通过引用被结合于此。
Claims (20)
1.一种用于治疗患者的慢性炎症的系统,所述系统包括:
可植入微刺激器,被配置为向迷走神经施加低占空比刺激,其中所述低占空比刺激每4小时仅提供单个超阈值脉冲;以及
控制器,被配置为设置用于所述微刺激器的剂量,其中所述剂量包括被至少4小时的关断周期跟随的所述单个超阈值脉冲。
2.根据权利要求1所述的系统,其中所述关断周期是至少24小时。
3.根据权利要求1所述的系统,其中所述关断周期是至少48小时。
4.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于5mA的脉冲振幅。
5.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于3mA的脉冲振幅。
6.根据权利要求1所述的系统,其中所述单个超阈值脉冲具有小于2mA的脉冲振幅。
7.根据权利要求1所述的系统,其中所述单个超阈值脉冲是双相的。
8.根据权利要求1所述的系统,其中所述慢性炎症是肠道炎症。
9.根据权利要求1所述的系统,其中所述慢性炎症是炎症性肠病。
10.根据权利要求1所述的系统,其中所述慢性炎症是克罗恩病。
11.一种治疗患者的慢性炎症的方法,所述方法包括:
植入微刺激器;以及
向迷走神经仅施加来自所述微刺激器的单个超阈值刺激脉冲,所述单个超阈值刺激脉冲被至少4小时的关断时间跟随。
12.根据权利要求11所述的方法,其中所述关断时间是至少24小时。
13.根据权利要求11所述的方法,其中所述关断时间是至少48小时。
14.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于5mA的脉冲振幅。
15.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于3mA的脉冲振幅。
16.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲具有小于2mA的脉冲振幅。
17.根据权利要求11所述的方法,其中所述单个超阈值刺激脉冲是双相的。
18.根据权利要求11所述的方法,其中所述慢性炎症是肠道炎症。
19.根据权利要求11所述的方法,其中所述慢性炎症是炎症性肠病。
20.根据权利要求11所述的方法,其中所述慢性炎症是克罗恩病。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161484112P | 2011-05-09 | 2011-05-09 | |
US61/484,112 | 2011-05-09 | ||
PCT/US2012/037142 WO2012154865A2 (en) | 2011-05-09 | 2012-05-09 | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103619405A true CN103619405A (zh) | 2014-03-05 |
CN103619405B CN103619405B (zh) | 2015-11-25 |
Family
ID=47139976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280031279.9A Active CN103619405B (zh) | 2011-05-09 | 2012-05-09 | 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8788034B2 (zh) |
EP (1) | EP2707094B1 (zh) |
CN (1) | CN103619405B (zh) |
WO (1) | WO2012154865A2 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108290041A (zh) * | 2015-04-24 | 2018-07-17 | 伽尔伐尼生物电子有限公司 | 神经调节设备 |
CN109069824A (zh) * | 2016-02-02 | 2018-12-21 | 阿莱瓦神经治疗股份有限公司 | 使用深部脑刺激治疗自身免疫疾病 |
US11266830B2 (en) | 2018-03-02 | 2022-03-08 | Aleva Neurotherapeutics | Neurostimulation device |
US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
US11730953B2 (en) | 2014-08-27 | 2023-08-22 | Aleva Neurotherapeutics | Deep brain stimulation lead |
US11766560B2 (en) | 2010-04-01 | 2023-09-26 | Ecole Polytechnique Federale De Lausanne | Device for interacting with neurological tissue and methods of making and using the same |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
EP1734941A2 (en) | 2004-03-25 | 2006-12-27 | The Feinstein Institute for Medical Research | Neural tourniquet |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
US8233976B2 (en) | 2007-12-05 | 2012-07-31 | The Invention Science Fund I, Llc | System for transdermal chemical modulation of neural activity |
US8160695B2 (en) * | 2007-12-05 | 2012-04-17 | The Invention Science Fund I, Llc | System for chemical modulation of neural activity |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
KR101719824B1 (ko) | 2008-05-09 | 2017-04-04 | 호라이라 인코포레이티드 | 기관지나무 치료용 시스템, 어셈블리 및 방법 |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US8996116B2 (en) * | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
WO2010144578A2 (en) | 2009-06-09 | 2010-12-16 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
CN104856757B (zh) | 2009-10-27 | 2017-06-23 | 赫莱拉公司 | 具有可冷却的能量发射组件的递送装置 |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
WO2014169145A1 (en) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
US20150241447A1 (en) * | 2009-11-17 | 2015-08-27 | Ralph J. ZITNIK | Vagus nerve stimulation screening test |
WO2011079309A2 (en) | 2009-12-23 | 2011-06-30 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
US20220072309A9 (en) * | 2011-05-09 | 2022-03-10 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9782584B2 (en) | 2014-06-13 | 2017-10-10 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
US10130809B2 (en) | 2014-06-13 | 2018-11-20 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
WO2016126807A1 (en) | 2015-02-03 | 2016-08-11 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
CN108882885A (zh) * | 2016-01-20 | 2018-11-23 | 赛博恩特医疗器械公司 | 迷走神经刺激的控制 |
EP3405255A4 (en) | 2016-01-20 | 2019-10-16 | Setpoint Medical Corporation | IMPLANTABLE MICROSTIMULATORS AND INDUCTION RECHARGE SYSTEMS |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
PL3481285T3 (pl) | 2016-07-07 | 2021-03-08 | The Regents Of The University Of California | Implanty wykorzystujące fale ultradźwiękowe do stymulacji tkanek |
US10335396B2 (en) | 2016-10-27 | 2019-07-02 | Patrick M. Nemechek | Methods of reversing autonomic nervous system damage |
WO2019036470A1 (en) | 2017-08-14 | 2019-02-21 | Setpoint Medical Corporation | TESTING TEST FOR STIMULATION OF NERVE WAVE |
EP3470111A1 (en) | 2017-10-13 | 2019-04-17 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
BR112020021383A2 (pt) | 2018-04-19 | 2021-01-26 | Iota Biosciences, Inc. | implantes que usam comunicação ultrassônica para detecção e estimulação neural |
CN112351812A (zh) | 2018-04-19 | 2021-02-09 | 艾奧塔生物科技公司 | 用于调节脾神经活动的使用超声通信的植入物 |
KR20210053915A (ko) | 2018-08-29 | 2021-05-12 | 아이오타 바이오사이언시즈 인코퍼레이티드 | 이식 가능한 폐회로 뉴로모듈레이션 장치, 시스템 및 사용 방법 |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
WO2020210786A1 (en) | 2019-04-12 | 2020-10-15 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
US11938324B2 (en) | 2020-05-21 | 2024-03-26 | The Feinstein Institutes For Medical Research | Systems and methods for vagus nerve stimulation |
US11123560B1 (en) | 2020-06-08 | 2021-09-21 | Patrick M. Nemechek | Methods of treating covid-19 induced cytokine storm |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080208266A1 (en) * | 2003-07-18 | 2008-08-28 | The Johns Hopkins University | System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation |
CN101528303A (zh) * | 2006-08-29 | 2009-09-09 | 心脏起搏器股份公司 | 用于神经刺激的系统 |
WO2010005482A1 (en) * | 2008-07-08 | 2010-01-14 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
WO2010067360A2 (en) * | 2008-12-09 | 2010-06-17 | Nephera Ltd. | Stimulation of the urinary system |
CN101868280A (zh) * | 2007-09-25 | 2010-10-20 | 心脏起搏器股份公司 | 用于心脏病症的神经刺激系统 |
US20110190849A1 (en) * | 2009-12-23 | 2011-08-04 | Faltys Michael A | Neural stimulation devices and systems for treatment of chronic inflammation |
Family Cites Families (450)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2164121A (en) | 1938-05-04 | 1939-06-27 | Pescador Hector | Electric hearing apparatus for the deaf |
US3363623A (en) | 1965-07-28 | 1968-01-16 | Charles F. Atwell | Hand-held double-acting nerve reflex massager |
FR2315274A1 (fr) | 1975-06-27 | 1977-01-21 | Parcor | Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications |
US4073296A (en) | 1976-01-02 | 1978-02-14 | Mccall Francis J | Apparatus for acupressure treatment |
US4098277A (en) | 1977-01-28 | 1978-07-04 | Sherwin Mendell | Fitted, integrally molded device for stimulating auricular acupuncture points and method of making the device |
US4305402A (en) | 1979-06-29 | 1981-12-15 | Katims Jefferson J | Method for transcutaneous electrical stimulation |
US4503863A (en) | 1979-06-29 | 1985-03-12 | Katims Jefferson J | Method and apparatus for transcutaneous electrical stimulation |
US5025807A (en) | 1983-09-14 | 1991-06-25 | Jacob Zabara | Neurocybernetic prosthesis |
US4867164A (en) | 1983-09-14 | 1989-09-19 | Jacob Zabara | Neurocybernetic prosthesis |
US4702254A (en) | 1983-09-14 | 1987-10-27 | Jacob Zabara | Neurocybernetic prosthesis |
US4590946A (en) | 1984-06-14 | 1986-05-27 | Biomed Concepts, Inc. | Surgically implantable electrode for nerve bundles |
US4573481A (en) | 1984-06-25 | 1986-03-04 | Huntington Institute Of Applied Research | Implantable electrode array |
US4649936A (en) | 1984-10-11 | 1987-03-17 | Case Western Reserve University | Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking |
US4632095A (en) | 1984-11-05 | 1986-12-30 | Tamiko Inc. | Pressure-point attachment for use with electrical hand-held massagers |
US4930516B1 (en) | 1985-11-13 | 1998-08-04 | Laser Diagnostic Instr Inc | Method for detecting cancerous tissue using visible native luminescence |
US4929734A (en) | 1987-03-31 | 1990-05-29 | Warner-Lambert Company | Tetrahydropyridine oxime compounds |
US4935234A (en) | 1987-06-11 | 1990-06-19 | Dana-Farber Cancer Institute | Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
US4840793A (en) | 1987-06-11 | 1989-06-20 | Dana-Farber Cancer Institute | Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
US5019648A (en) | 1987-07-06 | 1991-05-28 | Dana-Farber Cancer Institute | Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
DE3736664A1 (de) | 1987-10-29 | 1989-05-11 | Boehringer Ingelheim Kg | Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung |
US5038781A (en) | 1988-01-21 | 1991-08-13 | Hassan Hamedi | Multi-electrode neurological stimulation apparatus |
US5049659A (en) | 1988-02-09 | 1991-09-17 | Dana Farber Cancer Institute | Proteins which induce immunological effector cell activation and chemattraction |
US4920979A (en) | 1988-10-12 | 1990-05-01 | Huntington Medical Research Institute | Bidirectional helical electrode for nerve stimulation |
US4991578A (en) | 1989-04-04 | 1991-02-12 | Siemens-Pacesetter, Inc. | Method and system for implanting self-anchoring epicardial defibrillation electrodes |
US5106853A (en) | 1989-05-15 | 1992-04-21 | Merck Sharp & Dohme, Ltd. | Oxadiazole and its salts, their use in treating dementia |
US4979511A (en) | 1989-11-03 | 1990-12-25 | Cyberonics, Inc. | Strain relief tether for implantable electrode |
US5235980A (en) | 1989-11-13 | 1993-08-17 | Cyberonics, Inc. | Implanted apparatus disabling switching regulator operation to allow radio frequency signal reception |
US5154172A (en) | 1989-11-13 | 1992-10-13 | Cyberonics, Inc. | Constant current sources with programmable voltage source |
US5179950A (en) | 1989-11-13 | 1993-01-19 | Cyberonics, Inc. | Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not providing stimulation |
US5186170A (en) | 1989-11-13 | 1993-02-16 | Cyberonics, Inc. | Simultaneous radio frequency and magnetic field microprocessor reset circuit |
US5503978A (en) | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US6168778B1 (en) | 1990-06-11 | 2001-01-02 | Nexstar Pharmaceuticals, Inc. | Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
US5726017A (en) | 1990-06-11 | 1998-03-10 | Nexstar Pharmaceuticals, Inc. | High affinity HIV-1 gag nucleic acid ligands |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5712375A (en) | 1990-06-11 | 1998-01-27 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: tissue selex |
US5580737A (en) | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US6083696A (en) | 1990-06-11 | 2000-07-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands exponential enrichment: blended selex |
US5472841A (en) | 1990-06-11 | 1995-12-05 | Nexstar Pharmaceuticals, Inc. | Methods for identifying nucleic acid ligands of human neutrophil elastase |
US6140490A (en) | 1996-02-01 | 2000-10-31 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands of complement system proteins |
US5654151A (en) | 1990-06-11 | 1997-08-05 | Nexstar Pharmaceuticals, Inc. | High affinity HIV Nucleocapsid nucleic acid ligands |
US6147204A (en) | 1990-06-11 | 2000-11-14 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
ATE318832T1 (de) | 1990-06-11 | 2006-03-15 | Gilead Sciences Inc | Verfahren zur vervendung von nukleinsäureliganden |
US6127119A (en) | 1990-06-11 | 2000-10-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
US6124449A (en) | 1990-06-11 | 2000-09-26 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
US5111815A (en) | 1990-10-15 | 1992-05-12 | Cardiac Pacemakers, Inc. | Method and apparatus for cardioverter/pacer utilizing neurosensing |
US5188104A (en) | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5263480A (en) | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5269303A (en) | 1991-02-22 | 1993-12-14 | Cyberonics, Inc. | Treatment of dementia by nerve stimulation |
US5251634A (en) | 1991-05-03 | 1993-10-12 | Cyberonics, Inc. | Helical nerve electrode |
US5335657A (en) | 1991-05-03 | 1994-08-09 | Cyberonics, Inc. | Therapeutic treatment of sleep disorder by nerve stimulation |
US5215086A (en) | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
US5299569A (en) | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US6028186A (en) | 1991-06-10 | 2000-02-22 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands of cytokines |
US5205285A (en) | 1991-06-14 | 1993-04-27 | Cyberonics, Inc. | Voice suppression of vagal stimulation |
AU2339792A (en) | 1991-07-22 | 1993-02-23 | Cyberonics, Inc. | Treatment of respiratory disorders by nerve stimulation |
US5222494A (en) | 1991-07-31 | 1993-06-29 | Cyberonics, Inc. | Implantable tissue stimulator output stabilization system |
US5231988A (en) | 1991-08-09 | 1993-08-03 | Cyberonics, Inc. | Treatment of endocrine disorders by nerve stimulation |
US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
US5175166A (en) | 1991-08-27 | 1992-12-29 | The University Of Toledo | Muscarinic agonists |
US5215089A (en) | 1991-10-21 | 1993-06-01 | Cyberonics, Inc. | Electrode assembly for nerve stimulation |
US5304206A (en) | 1991-11-18 | 1994-04-19 | Cyberonics, Inc. | Activation techniques for implantable medical device |
US5237991A (en) | 1991-11-19 | 1993-08-24 | Cyberonics, Inc. | Implantable medical device with dummy load for pre-implant testing in sterile package and facilitating electrical lead connection |
US5203326A (en) | 1991-12-18 | 1993-04-20 | Telectronics Pacing Systems, Inc. | Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy |
US5330507A (en) | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
US5330515A (en) | 1992-06-17 | 1994-07-19 | Cyberonics, Inc. | Treatment of pain by vagal afferent stimulation |
US5977144A (en) | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
ATE230989T1 (de) | 1992-08-31 | 2003-02-15 | Univ Florida | Anabasein derivate zur behandlung von degenerativen erkrankungen des nervensystems |
JPH08506254A (ja) | 1993-02-10 | 1996-07-09 | シーメンス アクチエンゲゼルシヤフト | 鎮痛治療のための、および/または植物神経系に作用を与える装置および方法 |
US5344438A (en) | 1993-04-16 | 1994-09-06 | Medtronic, Inc. | Cuff electrode |
AU698101B2 (en) | 1993-06-01 | 1998-10-22 | Cortex Pharmaceuticals, Inc. | Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
US5594106A (en) | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
US5599984A (en) | 1994-01-21 | 1997-02-04 | The Picower Institute For Medical Research | Guanylhydrazones and their use to treat inflammatory conditions |
JP3269125B2 (ja) | 1994-01-28 | 2002-03-25 | 東レ株式会社 | アトピー性皮膚炎治療薬 |
ES2157326T3 (es) | 1994-04-22 | 2001-08-16 | Sanquin Bloedvoorziening | Sistema para el tratamiento de anomalias en la cascada de coagulacion sanguinea. |
US5458625A (en) | 1994-05-04 | 1995-10-17 | Kendall; Donald E. | Transcutaneous nerve stimulation device and method for using same |
US6017891A (en) | 1994-05-06 | 2000-01-25 | Baxter Aktiengesellschaft | Stable preparation for the treatment of blood coagulation disorders |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
PL183933B1 (pl) | 1994-08-24 | 2002-08-30 | Astra Ab | Związki spiroazabicyklo, sposób wytwarzania związku spiroazabicyklo i kompozycja farmaceutyczna |
US5531778A (en) | 1994-09-20 | 1996-07-02 | Cyberonics, Inc. | Circumneural electrode assembly |
US5540734A (en) | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US5571150A (en) | 1994-12-19 | 1996-11-05 | Cyberonics, Inc. | Treatment of patients in coma by nerve stimulation |
US5487756A (en) | 1994-12-23 | 1996-01-30 | Simon Fraser University | Implantable cuff having improved closure |
US5604231A (en) | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
US5540730A (en) | 1995-06-06 | 1996-07-30 | Cyberonics, Inc. | Treatment of motility disorders by nerve stimulation |
US5707400A (en) | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
US5700282A (en) | 1995-10-13 | 1997-12-23 | Zabara; Jacob | Heart rhythm stabilization using a neurocybernetic prosthesis |
WO1997014473A1 (en) | 1995-10-18 | 1997-04-24 | Novartis Ag | Thermopile powered transdermal drug delivery device |
US5611350A (en) | 1996-02-08 | 1997-03-18 | John; Michael S. | Method and apparatus for facilitating recovery of patients in deep coma |
US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US5913876A (en) | 1996-02-20 | 1999-06-22 | Cardiothoracic Systems, Inc. | Method and apparatus for using vagus nerve stimulation in surgery |
US5651378A (en) | 1996-02-20 | 1997-07-29 | Cardiothoracic Systems, Inc. | Method of using vagal nerve stimulation in surgery |
SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
DE59712322D1 (de) | 1996-03-20 | 2005-06-30 | Baxter Ag | Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen |
US5618818A (en) | 1996-03-20 | 1997-04-08 | The University Of Toledo | Muscarinic agonist compounds |
US5964794A (en) | 1996-03-21 | 1999-10-12 | Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin | Implantable stimulation electrode |
US5690681A (en) | 1996-03-29 | 1997-11-25 | Purdue Research Foundation | Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation |
US5726179A (en) | 1996-04-01 | 1998-03-10 | The University Of Toledo | Muscarinic agonists |
US6166048A (en) | 1999-04-20 | 2000-12-26 | Targacept, Inc. | Pharmaceutical compositions for inhibition of cytokine production and secretion |
US7225019B2 (en) | 1996-04-30 | 2007-05-29 | Medtronic, Inc. | Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure |
US7269457B2 (en) | 1996-04-30 | 2007-09-11 | Medtronic, Inc. | Method and system for vagal nerve stimulation with multi-site cardiac pacing |
US6449507B1 (en) | 1996-04-30 | 2002-09-10 | Medtronic, Inc. | Method and system for nerve stimulation prior to and during a medical procedure |
USRE38705E1 (en) | 1996-04-30 | 2005-02-22 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6628987B1 (en) | 2000-09-26 | 2003-09-30 | Medtronic, Inc. | Method and system for sensing cardiac contractions during vagal stimulation-induced cardiopalegia |
US6904318B2 (en) | 2000-09-26 | 2005-06-07 | Medtronic, Inc. | Method and system for monitoring and controlling systemic and pulmonary circulation during a medical procedure |
US20040199209A1 (en) | 2003-04-07 | 2004-10-07 | Hill Michael R.S. | Method and system for delivery of vasoactive drugs to the heart prior to and during a medical procedure |
US6532388B1 (en) | 1996-04-30 | 2003-03-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US6735471B2 (en) | 1996-04-30 | 2004-05-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US5853005A (en) | 1996-05-02 | 1998-12-29 | The United States Of America As Represented By The Secretary Of The Army | Acoustic monitoring system |
WO1997045160A1 (en) | 1996-05-31 | 1997-12-04 | Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
US5792210A (en) | 1996-06-10 | 1998-08-11 | Environmental Behavior Modification Inc. | Electrical tongue stimulator and method for addiction treatment |
JPH1094613A (ja) | 1996-08-02 | 1998-04-14 | Mieko Sato | 食欲調整用具 |
US5718912A (en) | 1996-10-28 | 1998-02-17 | Merck & Co., Inc. | Muscarine agonists |
ES2339306T3 (es) | 1996-11-15 | 2010-05-18 | Cytokine Pharmasciences, Inc. | Guanilhidrazonas utiles en el tratamiento de las enfermedades asociadas con la activacion de las celulas t. |
US6164284A (en) | 1997-02-26 | 2000-12-26 | Schulman; Joseph H. | System of implantable devices for monitoring and/or affecting body parameters |
US5788656A (en) | 1997-02-28 | 1998-08-04 | Mino; Alfonso Di | Electronic stimulation system for treating tinnitus disorders |
US5919216A (en) | 1997-06-16 | 1999-07-06 | Medtronic, Inc. | System and method for enhancement of glucose production by stimulation of pancreatic beta cells |
AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
US5824027A (en) | 1997-08-14 | 1998-10-20 | Simon Fraser University | Nerve cuff having one or more isolated chambers |
US6479523B1 (en) | 1997-08-26 | 2002-11-12 | Emory University | Pharmacologic drug combination in vagal-induced asystole |
US6011005A (en) | 1997-09-18 | 2000-01-04 | The Picower Institute For Medical Research | Prevention of pregnancy miscarriages |
US6141590A (en) | 1997-09-25 | 2000-10-31 | Medtronic, Inc. | System and method for respiration-modulated pacing |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US6018682A (en) | 1998-04-30 | 2000-01-25 | Medtronic, Inc. | Implantable seizure warning system |
US5928272A (en) | 1998-05-02 | 1999-07-27 | Cyberonics, Inc. | Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity |
US6002964A (en) | 1998-07-15 | 1999-12-14 | Feler; Claudio A. | Epidural nerve root stimulation |
US7599736B2 (en) | 2001-07-23 | 2009-10-06 | Dilorenzo Biomedical, Llc | Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease |
US7242984B2 (en) | 1998-08-05 | 2007-07-10 | Neurovista Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US8762065B2 (en) | 1998-08-05 | 2014-06-24 | Cyberonics, Inc. | Closed-loop feedback-driven neuromodulation |
US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US6208902B1 (en) | 1998-10-26 | 2001-03-27 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy for pain syndromes utilizing an implantable lead and an external stimulator |
US6615081B1 (en) | 1998-10-26 | 2003-09-02 | Birinder R. Boveja | Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator |
US7076307B2 (en) | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
US6611715B1 (en) | 1998-10-26 | 2003-08-26 | Birinder R. Boveja | Apparatus and method for neuromodulation therapy for obesity and compulsive eating disorders using an implantable lead-receiver and an external stimulator |
US6505074B2 (en) | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
US6564102B1 (en) | 1998-10-26 | 2003-05-13 | Birinder R. Boveja | Apparatus and method for adjunct (add-on) treatment of coma and traumatic brain injury with neuromodulation using an external stimulator |
US6205359B1 (en) | 1998-10-26 | 2001-03-20 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
US6356788B2 (en) | 1998-10-26 | 2002-03-12 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
US6668191B1 (en) | 1998-10-26 | 2003-12-23 | Birinder R. Boveja | Apparatus and method for electrical stimulation adjunct (add-on) therapy of atrial fibrillation, inappropriate sinus tachycardia, and refractory hypertension with an external stimulator |
US20030212440A1 (en) | 2002-05-09 | 2003-11-13 | Boveja Birinder R. | Method and system for modulating the vagus nerve (10th cranial nerve) using modulated electrical pulses with an inductively coupled stimulation system |
US6366814B1 (en) | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
US6269270B1 (en) | 1998-10-26 | 2001-07-31 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator |
US20050137644A1 (en) | 1998-10-26 | 2005-06-23 | Boveja Birinder R. | Method and system for vagal blocking and/or vagal stimulation to provide therapy for obesity and other gastrointestinal disorders |
US5994330A (en) | 1998-11-09 | 1999-11-30 | El Khoury; Georges F. | Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions |
FR2786770B1 (fr) | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
US6376675B2 (en) | 1999-01-22 | 2002-04-23 | The University Of Toledo | Muscarinic receptor agonists |
US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
US6233488B1 (en) | 1999-06-25 | 2001-05-15 | Carl A. Hess | Spinal cord stimulation as a treatment for addiction to nicotine and other chemical substances |
EP1198271A4 (en) | 1999-06-25 | 2009-01-21 | Univ Emory | DEVICES AND METHODS FOR STIMULATING THE VAGUSNERVS |
US6587719B1 (en) | 1999-07-01 | 2003-07-01 | Cyberonics, Inc. | Treatment of obesity by bilateral vagus nerve stimulation |
US6804558B2 (en) | 1999-07-07 | 2004-10-12 | Medtronic, Inc. | System and method of communicating between an implantable medical device and a remote computer system or health care provider |
US6210321B1 (en) | 1999-07-29 | 2001-04-03 | Adm Tronics Unlimited, Inc. | Electronic stimulation system for treating tinnitus disorders |
US6171795B1 (en) | 1999-07-29 | 2001-01-09 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to CD40ligand |
US6304775B1 (en) | 1999-09-22 | 2001-10-16 | Leonidas D. Iasemidis | Seizure warning and prediction |
US6636767B1 (en) | 1999-09-29 | 2003-10-21 | Restore Medical, Inc. | Implanatable stimulation device for snoring treatment |
US6473644B1 (en) | 1999-10-13 | 2002-10-29 | Cyberonics, Inc. | Method to enhance cardiac capillary growth in heart failure patients |
US20020026141A1 (en) | 1999-11-04 | 2002-02-28 | Medtronic, Inc. | System for pancreatic stimulation and glucose measurement |
FR2803186B1 (fr) | 2000-01-05 | 2002-08-09 | Guy Charvin | Procede et dispositif de recueil de potentiels evoques auditif |
US6447443B1 (en) | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
US6356787B1 (en) | 2000-02-24 | 2002-03-12 | Electro Core Techniques, Llc | Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain |
US20060085046A1 (en) | 2000-01-20 | 2006-04-20 | Ali Rezai | Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system |
US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
JP2003530169A (ja) | 2000-04-11 | 2003-10-14 | ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム | 胃腸管の電気刺激 |
US6826428B1 (en) | 2000-04-11 | 2004-11-30 | The Board Of Regents Of The University Of Texas System | Gastrointestinal electrical stimulation |
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US6511500B1 (en) | 2000-06-06 | 2003-01-28 | Marc Mounir Rahme | Use of autonomic nervous system neurotransmitters inhibition and atrial parasympathetic fibers ablation for the treatment of atrial arrhythmias and to preserve drug effects |
AU2001282873A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6487446B1 (en) | 2000-09-26 | 2002-11-26 | Medtronic, Inc. | Method and system for spinal cord stimulation prior to and during a medical procedure |
WO2002026140A1 (en) | 2000-09-26 | 2002-04-04 | Medtronic, Inc. | Medical method and system for directing blood flow |
US20020077675A1 (en) | 2000-09-26 | 2002-06-20 | Transneuronix, Inc. | Minimally invasive surgery placement of stimulation leads in mediastinal structures |
EP1326678A2 (en) | 2000-10-11 | 2003-07-16 | Ronald R. Riso | Nerve cuff electrode |
US7011638B2 (en) | 2000-11-14 | 2006-03-14 | Science Medicus, Inc. | Device and procedure to treat cardiac atrial arrhythmias |
US6832114B1 (en) | 2000-11-21 | 2004-12-14 | Advanced Bionics Corporation | Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes |
US6633779B1 (en) | 2000-11-27 | 2003-10-14 | Science Medicus, Inc. | Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms |
US6884807B2 (en) | 2000-12-01 | 2005-04-26 | Neurosearch, A/S | 3-substituted quinuclidines and their use as nicotinic agonists |
US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
US6609025B2 (en) | 2001-01-02 | 2003-08-19 | Cyberonics, Inc. | Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation |
US7519421B2 (en) | 2001-01-16 | 2009-04-14 | Kenergy, Inc. | Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation |
WO2002057275A1 (en) | 2001-01-17 | 2002-07-25 | University Of Kentucky Research Foundation | Boron-containing nicotine analogs for use in the treatment of cns pathologies |
US6735475B1 (en) | 2001-01-30 | 2004-05-11 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain |
US7167751B1 (en) | 2001-03-01 | 2007-01-23 | Advanced Bionics Corporation | Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation |
JP2004524125A (ja) | 2001-04-05 | 2004-08-12 | メド−エル・エレクトロメディツィニシェ・ゲラーテ・ゲーエムベーハー | 両側声帯自律麻痺のためのペースメーカー |
US7369897B2 (en) | 2001-04-19 | 2008-05-06 | Neuro And Cardiac Technologies, Llc | Method and system of remotely controlling electrical pulses provided to nerve tissue(s) by an implanted stimulator system for neuromodulation therapies |
US20050240229A1 (en) | 2001-04-26 | 2005-10-27 | Whitehurst Tood K | Methods and systems for stimulation as a therapy for erectile dysfunction |
US6684105B2 (en) | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US6928320B2 (en) | 2001-05-17 | 2005-08-09 | Medtronic, Inc. | Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated |
US6947782B2 (en) | 2001-06-18 | 2005-09-20 | Alfred E. Mann Foundation For Scientific Research | Miniature implantable connectors |
US7054692B1 (en) | 2001-06-22 | 2006-05-30 | Advanced Bionics Corporation | Fixation device for implantable microdevices |
US20060167498A1 (en) | 2001-07-23 | 2006-07-27 | Dilorenzo Daniel J | Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease |
US20060116736A1 (en) | 2001-07-23 | 2006-06-01 | Dilorenzo Daniel J | Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity |
US6622038B2 (en) | 2001-07-28 | 2003-09-16 | Cyberonics, Inc. | Treatment of movement disorders by near-diaphragmatic nerve stimulation |
US6622047B2 (en) | 2001-07-28 | 2003-09-16 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation |
US6622041B2 (en) | 2001-08-21 | 2003-09-16 | Cyberonics, Inc. | Treatment of congestive heart failure and autonomic cardiovascular drive disorders |
US6600956B2 (en) | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US6760626B1 (en) | 2001-08-29 | 2004-07-06 | Birinder R. Boveja | Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system |
US7054686B2 (en) | 2001-08-30 | 2006-05-30 | Biophan Technologies, Inc. | Pulsewidth electrical stimulation |
US7778703B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Selective nerve fiber stimulation for treating heart conditions |
US7734355B2 (en) | 2001-08-31 | 2010-06-08 | Bio Control Medical (B.C.M.) Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US8615294B2 (en) | 2008-08-13 | 2013-12-24 | Bio Control Medical (B.C.M.) Ltd. | Electrode devices for nerve stimulation and cardiac sensing |
US7974693B2 (en) | 2001-08-31 | 2011-07-05 | Bio Control Medical (B.C.M.) Ltd. | Techniques for applying, configuring, and coordinating nerve fiber stimulation |
US7885709B2 (en) | 2001-08-31 | 2011-02-08 | Bio Control Medical (B.C.M.) Ltd. | Nerve stimulation for treating disorders |
US7778711B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Reduction of heart rate variability by parasympathetic stimulation |
US6934583B2 (en) | 2001-10-22 | 2005-08-23 | Pacesetter, Inc. | Implantable lead and method for stimulating the vagus nerve |
US6745079B2 (en) | 2001-11-07 | 2004-06-01 | Medtronic, Inc. | Electrical tissue stimulation apparatus and method |
US7155284B1 (en) | 2002-01-24 | 2006-12-26 | Advanced Bionics Corporation | Treatment of hypertension |
US6721603B2 (en) | 2002-01-25 | 2004-04-13 | Cyberonics, Inc. | Nerve stimulation as a treatment for pain |
AU2003217747A1 (en) | 2002-02-26 | 2003-09-09 | North Shore-Long Island Jewish Research Insitute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
US7689276B2 (en) | 2002-09-13 | 2010-03-30 | Leptos Biomedical, Inc. | Dynamic nerve stimulation for treatment of disorders |
US7937145B2 (en) | 2002-03-22 | 2011-05-03 | Advanced Neuromodulation Systems, Inc. | Dynamic nerve stimulation employing frequency modulation |
US7465555B2 (en) | 2002-04-02 | 2008-12-16 | Becton, Dickinson And Company | Early detection of sepsis |
US6978787B1 (en) | 2002-04-03 | 2005-12-27 | Michael Broniatowski | Method and system for dynamic vocal fold closure with neuro-electrical stimulation |
US20030191404A1 (en) | 2002-04-08 | 2003-10-09 | Klein George J. | Method and apparatus for providing arrhythmia discrimination |
US20050177200A1 (en) | 2002-05-03 | 2005-08-11 | George Mark S. | Method, apparatus and system for determining effects and optimizing parameters of vagus nerve stimulation |
US20050209654A1 (en) | 2002-05-09 | 2005-09-22 | Boveja Birinder R | Method and system for providing adjunct (add-on) therapy for depression, anxiety and obsessive-compulsive disorders by providing electrical pulses to vagus nerve(s) |
US20060079936A1 (en) | 2003-05-11 | 2006-04-13 | Boveja Birinder R | Method and system for altering regional cerebral blood flow (rCBF) by providing complex and/or rectangular electrical pulses to vagus nerve(s), to provide therapy for depression and other medical disorders |
US20050165458A1 (en) | 2002-05-09 | 2005-07-28 | Boveja Birinder R. | Method and system to provide therapy for depression using electroconvulsive therapy(ECT) and pulsed electrical stimulation to vagus nerve(s) |
US20060009815A1 (en) | 2002-05-09 | 2006-01-12 | Boveja Birinder R | Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s) |
US20070067004A1 (en) | 2002-05-09 | 2007-03-22 | Boveja Birinder R | Methods and systems for modulating the vagus nerve (10th cranial nerve) to provide therapy for neurological, and neuropsychiatric disorders |
US7191012B2 (en) | 2003-05-11 | 2007-03-13 | Boveja Birinder R | Method and system for providing pulsed electrical stimulation to a craniel nerve of a patient to provide therapy for neurological and neuropsychiatric disorders |
US20050154426A1 (en) | 2002-05-09 | 2005-07-14 | Boveja Birinder R. | Method and system for providing therapy for neuropsychiatric and neurological disorders utilizing transcranical magnetic stimulation and pulsed electrical vagus nerve(s) stimulation |
US20050216070A1 (en) | 2002-05-09 | 2005-09-29 | Boveja Birinder R | Method and system for providing therapy for migraine/chronic headache by providing electrical pulses to vagus nerve(s) |
US8036745B2 (en) | 2004-06-10 | 2011-10-11 | Bio Control Medical (B.C.M.) Ltd. | Parasympathetic pacing therapy during and following a medical procedure, clinical trauma or pathology |
US7321793B2 (en) | 2003-06-13 | 2008-01-22 | Biocontrol Medical Ltd. | Vagal stimulation for atrial fibrillation therapy |
US20060116739A1 (en) | 2002-05-23 | 2006-06-01 | Nir Betser | Electrode assembly for nerve control |
US7277761B2 (en) | 2002-06-12 | 2007-10-02 | Pacesetter, Inc. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US20040015202A1 (en) | 2002-06-14 | 2004-01-22 | Chandler Gilbert S. | Combination epidural infusion/stimulation method and system |
US20040015205A1 (en) | 2002-06-20 | 2004-01-22 | Whitehurst Todd K. | Implantable microstimulators with programmable multielectrode configuration and uses thereof |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
US7203548B2 (en) | 2002-06-20 | 2007-04-10 | Advanced Bionics Corporation | Cavernous nerve stimulation via unidirectional propagation of action potentials |
KR100553516B1 (ko) | 2002-06-24 | 2006-02-20 | 정종필 | 알파파유도 전기자극기 |
US20040049121A1 (en) | 2002-09-06 | 2004-03-11 | Uri Yaron | Positioning system for neurological procedures in the brain |
US7209790B2 (en) | 2002-09-30 | 2007-04-24 | Medtronic, Inc. | Multi-mode programmer for medical device communication |
AU2003301370A1 (en) | 2002-10-15 | 2004-05-04 | Medtronic Inc. | Multi-modal operation of a medical device system |
AU2003301255A1 (en) | 2002-10-15 | 2004-05-04 | Medtronic Inc. | Screening techniques for management of a nervous system disorder |
EP1558131A4 (en) | 2002-10-15 | 2008-05-28 | Medtronic Inc | DELAYING THE RE-ADMINISTRATION OF A TREATMENT FOR A MEDICAL DEVICE SYSTEM |
AU2003285888A1 (en) | 2002-10-15 | 2004-05-04 | Medtronic Inc. | Medical device system with relaying module for treatment of nervous system disorders |
AU2003284968A1 (en) | 2002-10-25 | 2004-05-13 | University Of South Florida | Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
US20030229380A1 (en) | 2002-10-31 | 2003-12-11 | Adams John M. | Heart failure therapy device and method |
US7305265B2 (en) | 2002-11-25 | 2007-12-04 | Terumo Kabushiki Kaisha | Heart treatment equipment for treating heart failure |
US7142917B2 (en) | 2002-12-04 | 2006-11-28 | Terumo Kabushiki Kaisha | Heart treatment equipment and method for preventing fatal arrhythmia |
US7238715B2 (en) | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
JP4750421B2 (ja) | 2002-12-06 | 2011-08-17 | ノース ショア−ロング アイランド ジュ−イッシュ リサ−チ インスティチュ−ト | α7受容体結合コリン作動性アゴニストを用いる炎症の阻害 |
US20040111139A1 (en) | 2002-12-10 | 2004-06-10 | Mccreery Douglas B. | Apparatus and methods for differential stimulation of nerve fibers |
TR200202651A2 (tr) | 2002-12-12 | 2004-07-21 | Met�N�Tulgar | VücutÁdışındanÁdirekÁtedaviÁsinyaliÁtransferliÁÁbeyinÁpili |
JP2004201901A (ja) | 2002-12-25 | 2004-07-22 | Yoshimi Kurokawa | 胃電気刺激装置 |
WO2004064918A1 (en) | 2003-01-14 | 2004-08-05 | Department Of Veterans Affairs, Office Of General Counsel | Cervical wagal stimulation induced weight loss |
WO2004064729A2 (en) | 2003-01-15 | 2004-08-05 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Treatments for snoring using injectable neuromuscular stimulators |
US20050143781A1 (en) | 2003-01-31 | 2005-06-30 | Rafael Carbunaru | Methods and systems for patient adjustment of parameters for an implanted stimulator |
US20040172084A1 (en) | 2003-02-03 | 2004-09-02 | Knudson Mark B. | Method and apparatus for treatment of gastro-esophageal reflux disease (GERD) |
US7444183B2 (en) | 2003-02-03 | 2008-10-28 | Enteromedics, Inc. | Intraluminal electrode apparatus and method |
CN1964630A (zh) | 2003-02-13 | 2007-05-16 | 耶希瓦大学艾伯塔·爱恩斯坦医学院 | 通过控制下丘脑的长链脂肪酰基-辅酶A(LC-CoA)的水平来调控食物摄取和葡萄糖产生 |
US7269455B2 (en) | 2003-02-26 | 2007-09-11 | Pineda Jaime A | Method and system for predicting and preventing seizures |
US7430449B2 (en) | 2003-03-14 | 2008-09-30 | Endovx, Inc. | Methods and apparatus for testing disruption of a vagal nerve |
US7783358B2 (en) | 2003-03-14 | 2010-08-24 | Endovx, Inc. | Methods and apparatus for treatment of obesity with an ultrasound device movable in two or three axes |
US6814418B2 (en) | 2003-03-14 | 2004-11-09 | D'orso Ronald | Locker organizer |
US20060015151A1 (en) | 2003-03-14 | 2006-01-19 | Aldrich William N | Method of using endoscopic truncal vagoscopy with gastric bypass, gastric banding and other procedures |
JP4252830B2 (ja) | 2003-03-24 | 2009-04-08 | テルモ株式会社 | 心臓治療装置 |
US7155279B2 (en) | 2003-03-28 | 2006-12-26 | Advanced Bionics Corporation | Treatment of movement disorders with drug therapy |
US7228167B2 (en) | 2003-04-10 | 2007-06-05 | Mayo Foundation For Medical Education | Method and apparatus for detecting vagus nerve stimulation |
US7706871B2 (en) | 2003-05-06 | 2010-04-27 | Nellcor Puritan Bennett Llc | System and method of prediction of response to neurological treatment using the electroencephalogram |
WO2004100765A2 (en) | 2003-05-06 | 2004-11-25 | Aspect Medical Systems, Inc. | System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram |
DE10320863B3 (de) | 2003-05-09 | 2004-11-11 | Siemens Audiologische Technik Gmbh | Befestigung eines Hörhilfegerätes oder einer Otoplastik im Ohr |
US20050187590A1 (en) | 2003-05-11 | 2005-08-25 | Boveja Birinder R. | Method and system for providing therapy for autism by providing electrical pulses to the vagus nerve(s) |
US20050197678A1 (en) | 2003-05-11 | 2005-09-08 | Boveja Birinder R. | Method and system for providing therapy for Alzheimer's disease and dementia by providing electrical pulses to vagus nerve(s) |
US7444184B2 (en) | 2003-05-11 | 2008-10-28 | Neuro And Cardial Technologies, Llc | Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s) |
US20060074450A1 (en) | 2003-05-11 | 2006-04-06 | Boveja Birinder R | System for providing electrical pulses to nerve and/or muscle using an implanted stimulator |
US20060173508A1 (en) | 2003-05-16 | 2006-08-03 | Stone Robert T | Method and system for treatment of eating disorders by means of neuro-electrical coded signals |
US20060287679A1 (en) | 2003-05-16 | 2006-12-21 | Stone Robert T | Method and system to control respiration by means of confounding neuro-electrical signals |
US20060111755A1 (en) | 2003-05-16 | 2006-05-25 | Stone Robert T | Method and system to control respiration by means of neuro-electrical coded signals |
JP2007500576A (ja) | 2003-05-16 | 2007-01-18 | サイエンス・メディカス・インコーポレイテッド | 神経電気コード化信号による呼吸制御 |
US20060064137A1 (en) | 2003-05-16 | 2006-03-23 | Stone Robert T | Method and system to control respiration by means of simulated action potential signals |
US7620454B2 (en) | 2003-05-19 | 2009-11-17 | Medtronic, Inc. | Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof |
US7742818B2 (en) | 2003-05-19 | 2010-06-22 | Medtronic, Inc. | Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof |
US20100010603A1 (en) | 2008-07-09 | 2010-01-14 | Tamir Ben-David | Electrode cuffs |
JP4213522B2 (ja) | 2003-05-30 | 2009-01-21 | テルモ株式会社 | 心臓治療装置 |
US7738952B2 (en) | 2003-06-09 | 2010-06-15 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
WO2004110549A2 (en) * | 2003-06-13 | 2004-12-23 | Biocontrol Medical Ltd. | Applications of vagal stimulation |
EP1648560A4 (en) | 2003-06-13 | 2015-10-28 | Biocontrol Medical Ltd | VAGAL STIMULATION FOR ANTI-EMBOLIC THERAPY |
DE10328816A1 (de) | 2003-06-21 | 2005-01-05 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit |
JP2007530417A (ja) | 2003-07-01 | 2007-11-01 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 細胞及び生物の寿命及びストレス応答を操作するための組成物 |
US7174218B1 (en) | 2003-08-12 | 2007-02-06 | Advanced Bionics Corporation | Lead extension system for use with a microstimulator |
JP4439215B2 (ja) | 2003-08-26 | 2010-03-24 | テルモ株式会社 | 心臓治療装置 |
US7263405B2 (en) | 2003-08-27 | 2007-08-28 | Neuro And Cardiac Technologies Llc | System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities |
US7797058B2 (en) | 2004-08-04 | 2010-09-14 | Ndi Medical, Llc | Devices, systems, and methods employing a molded nerve cuff electrode |
US20050070970A1 (en) | 2003-09-29 | 2005-03-31 | Knudson Mark B. | Movement disorder stimulation with neural block |
US20050070974A1 (en) | 2003-09-29 | 2005-03-31 | Knudson Mark B. | Obesity and eating disorder stimulation treatment with neural block |
US20050075702A1 (en) | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for inhibiting release of pro-inflammatory mediator |
US7418292B2 (en) | 2003-10-01 | 2008-08-26 | Medtronic, Inc. | Device and method for attenuating an immune response |
US20050153885A1 (en) | 2003-10-08 | 2005-07-14 | Yun Anthony J. | Treatment of conditions through modulation of the autonomic nervous system |
US7062320B2 (en) | 2003-10-14 | 2006-06-13 | Ehlinger Jr Philip Charles | Device for the treatment of hiccups |
AU2004283720A1 (en) | 2003-10-24 | 2005-05-06 | Medtronic, Inc. | Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
DE20316509U1 (de) | 2003-10-27 | 2004-03-11 | Lukl, Alfred | Akupressur- und Massagegerät für das menschliche Ohr |
US20050131467A1 (en) | 2003-11-02 | 2005-06-16 | Boveja Birinder R. | Method and apparatus for electrical stimulation therapy for at least one of atrial fibrillation, congestive heart failure, inappropriate sinus tachycardia, and refractory hypertension |
WO2005051451A2 (en) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Electrical devices and anti-scarring agents |
US20050137645A1 (en) | 2003-12-05 | 2005-06-23 | Juha Voipio | Novel method for the adjustment of human and animal vagus nerve stimulation |
US7769461B2 (en) | 2003-12-19 | 2010-08-03 | Boston Scientific Neuromodulation Corporation | Skull-mounted electrical stimulation system and method for treating patients |
US7486991B2 (en) | 2003-12-24 | 2009-02-03 | Cardiac Pacemakers, Inc. | Baroreflex modulation to gradually decrease blood pressure |
US20050149129A1 (en) | 2003-12-24 | 2005-07-07 | Imad Libbus | Baropacing and cardiac pacing to control output |
US7460906B2 (en) | 2003-12-24 | 2008-12-02 | Cardiac Pacemakers, Inc. | Baroreflex stimulation to treat acute myocardial infarction |
US7422555B2 (en) | 2003-12-30 | 2008-09-09 | Jacob Zabara | Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses |
US8147561B2 (en) | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
WO2005089646A1 (en) | 2004-03-16 | 2005-09-29 | Medtronic, Inc. | Sensitivity analysis for selecting therapy parameter sets |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
EP1734941A2 (en) | 2004-03-25 | 2006-12-27 | The Feinstein Institute for Medical Research | Neural tourniquet |
EP1750799A2 (en) | 2004-05-04 | 2007-02-14 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the sympathetic nervous system |
US20060111644A1 (en) | 2004-05-27 | 2006-05-25 | Children's Medical Center Corporation | Patient-specific seizure onset detection system |
JP2008501343A (ja) | 2004-06-04 | 2008-01-24 | ワシントン・ユニバーシティ | 神経障害を治療するための方法および組成物 |
US7565197B2 (en) | 2004-06-18 | 2009-07-21 | Medtronic, Inc. | Conditional requirements for remote medical device programming |
US7664551B2 (en) | 2004-07-07 | 2010-02-16 | Medtronic Transneuronix, Inc. | Treatment of the autonomic nervous system |
US7711432B2 (en) | 2004-07-26 | 2010-05-04 | Advanced Neuromodulation Systems, Inc. | Stimulation system and method for treating a neurological disorder |
US20060025828A1 (en) | 2004-07-28 | 2006-02-02 | Armstrong Randolph K | Impedance measurement for an implantable device |
US7204815B2 (en) | 2004-08-11 | 2007-04-17 | Georgia K. Connor | Mastoid ear cuff and system |
US8452407B2 (en) | 2004-08-16 | 2013-05-28 | Boston Scientific Neuromodulation Corporation | Methods for treating gastrointestinal disorders |
US20050154425A1 (en) | 2004-08-19 | 2005-07-14 | Boveja Birinder R. | Method and system to provide therapy for neuropsychiatric disorders and cognitive impairments using gradient magnetic pulses to the brain and pulsed electrical stimulation to vagus nerve(s) |
US7337006B2 (en) | 2004-09-08 | 2008-02-26 | Spinal Modulation, Inc. | Methods and systems for modulating neural tissue |
WO2006045054A2 (en) | 2004-10-18 | 2006-04-27 | E-Soc | Device for neuromusclar, peripheral body stimulation and electrical stimulation (es) for wound healing using rf energy harvesting |
WO2006047264A1 (en) | 2004-10-21 | 2006-05-04 | Advanced Neuromodulation Systems, Inc. | Peripheral nerve stimulation to treat auditory dysfunction |
US7672733B2 (en) | 2004-10-29 | 2010-03-02 | Medtronic, Inc. | Methods and apparatus for sensing cardiac activity via neurological stimulation therapy system or medical electrical lead |
US7818342B2 (en) | 2004-11-12 | 2010-10-19 | Sap Ag | Tracking usage of data elements in electronic business communications |
US8332047B2 (en) | 2004-11-18 | 2012-12-11 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
US9089691B2 (en) | 2004-12-07 | 2015-07-28 | Cardiac Pacemakers, Inc. | Stimulator for auricular branch of vagus nerve |
US7366571B2 (en) | 2004-12-10 | 2008-04-29 | Cyberonics, Inc. | Neurostimulator with activation based on changes in body temperature |
US20060161217A1 (en) | 2004-12-21 | 2006-07-20 | Jaax Kristen N | Methods and systems for treating obesity |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
WO2006073484A2 (en) | 2004-12-27 | 2006-07-13 | North Shore-Long Island Jewish Research Institute | Treating inflammatory disorders by electrical vagus nerve stimulation |
JP2008527002A (ja) | 2005-01-13 | 2008-07-24 | サートリス ファーマシューティカルズ, インコーポレイテッド | 神経変性障害および血液凝固障害を予防および処置するための新規組成物 |
US8825166B2 (en) | 2005-01-21 | 2014-09-02 | John Sasha John | Multiple-symptom medical treatment with roving-based neurostimulation |
US8788044B2 (en) | 2005-01-21 | 2014-07-22 | Michael Sasha John | Systems and methods for tissue stimulation in medical treatment |
US8609082B2 (en) | 2005-01-25 | 2013-12-17 | Bio Control Medical Ltd. | Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis |
DE102005003735B4 (de) | 2005-01-26 | 2008-04-03 | Cerbomed Gmbh | Vorrichtung zur transkutanen Stimulation eines Nervs des menschlichen Körpers |
US8600521B2 (en) | 2005-01-27 | 2013-12-03 | Cyberonics, Inc. | Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity |
US7561918B2 (en) | 2005-01-28 | 2009-07-14 | Cyberonics, Inc. | Autocapture in a neurostimulator |
US20060173493A1 (en) | 2005-01-28 | 2006-08-03 | Cyberonics, Inc. | Multi-phasic signal for stimulation by an implantable device |
EP1846094B1 (en) | 2005-02-02 | 2011-10-05 | NuVasive, Inc. | System for performing neurophysiologic assessments during surgery |
EP1848820A2 (en) | 2005-02-08 | 2007-10-31 | Janssen Pharmaceutica N.V. | Vagal afferent neurons as targets for treatment |
US8185199B2 (en) | 2005-02-10 | 2012-05-22 | Zoll Medical Corporation | Monitoring physiological signals during external electrical stimulation |
US7548780B2 (en) | 2005-02-22 | 2009-06-16 | Cardiac Pacemakers, Inc. | Cell therapy and neural stimulation for cardiac repair |
US20060200219A1 (en) | 2005-03-01 | 2006-09-07 | Ndi Medical, Llc | Systems and methods for differentiating and/or identifying tissue regions innervated by targeted nerves for diagnostic and/or therapeutic purposes |
US8700163B2 (en) | 2005-03-04 | 2014-04-15 | Cyberonics, Inc. | Cranial nerve stimulation for treatment of substance addiction |
US7613511B2 (en) | 2005-03-09 | 2009-11-03 | Cardiac Pacemakers, Inc. | Implantable vagal stimulator for treating cardiac ischemia |
US20060229681A1 (en) | 2005-04-11 | 2006-10-12 | Fischell Robert E | Implantable system for the treatment of atrial fibrillation |
US7499748B2 (en) | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
US7881782B2 (en) | 2005-04-20 | 2011-02-01 | Cardiac Pacemakers, Inc. | Neural stimulation system to prevent simultaneous energy discharges |
US20060282121A1 (en) | 2005-04-25 | 2006-12-14 | Payne Bryan R | Vagus nerve stimulation for chronic intractable hiccups |
US7310557B2 (en) | 2005-04-29 | 2007-12-18 | Maschino Steven E | Identification of electrodes for nerve stimulation in the treatment of eating disorders |
US7835796B2 (en) | 2005-04-29 | 2010-11-16 | Cyberonics, Inc. | Weight loss method and device |
US7899540B2 (en) | 2005-04-29 | 2011-03-01 | Cyberonics, Inc. | Noninvasively adjustable gastric band |
US7734348B2 (en) | 2005-05-10 | 2010-06-08 | Cardiac Pacemakers, Inc. | System with left/right pulmonary artery electrodes |
US7765000B2 (en) | 2005-05-10 | 2010-07-27 | Cardiac Pacemakers, Inc. | Neural stimulation system with pulmonary artery lead |
US7617003B2 (en) | 2005-05-16 | 2009-11-10 | Cardiac Pacemakers, Inc. | System for selective activation of a nerve trunk using a transvascular reshaping lead |
US20060292099A1 (en) | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
US7584004B2 (en) | 2005-06-13 | 2009-09-01 | Cardiac Pacemakers, Inc. | Vascularly stabilized peripheral nerve cuff assembly |
US8036750B2 (en) | 2005-06-13 | 2011-10-11 | Cardiac Pacemakers, Inc. | System for neural control of respiration |
US20060293721A1 (en) | 2005-06-28 | 2006-12-28 | Cyberonics, Inc. | Vagus nerve stimulation for treatment of depression with therapeutically beneficial parameter settings |
US20070016262A1 (en) | 2005-07-13 | 2007-01-18 | Betastim, Ltd. | Gi and pancreatic device for treating obesity and diabetes |
US7711419B2 (en) | 2005-07-13 | 2010-05-04 | Cyberonics, Inc. | Neurostimulator with reduced size |
US8140159B2 (en) | 2005-07-21 | 2012-03-20 | Cyberonics, Inc. | Safe-mode operation of an implantable medical device |
US20070021786A1 (en) | 2005-07-25 | 2007-01-25 | Cyberonics, Inc. | Selective nerve stimulation for the treatment of angina pectoris |
US20070027497A1 (en) | 2005-07-27 | 2007-02-01 | Cyberonics, Inc. | Nerve stimulation for treatment of syncope |
US20070027504A1 (en) | 2005-07-27 | 2007-02-01 | Cyberonics, Inc. | Cranial nerve stimulation to treat a hearing disorder |
US7840280B2 (en) | 2005-07-27 | 2010-11-23 | Cyberonics, Inc. | Cranial nerve stimulation to treat a vocal cord disorder |
US20070027484A1 (en) | 2005-07-28 | 2007-02-01 | Cyberonics, Inc. | Autonomic nerve stimulation to treat a pancreatic disorder |
US7856273B2 (en) | 2005-07-28 | 2010-12-21 | Cyberonics, Inc. | Autonomic nerve stimulation to treat a gastrointestinal disorder |
US8660647B2 (en) | 2005-07-28 | 2014-02-25 | Cyberonics, Inc. | Stimulating cranial nerve to treat pulmonary disorder |
US7706874B2 (en) | 2005-07-28 | 2010-04-27 | Cyberonics, Inc. | Stimulating cranial nerve to treat disorders associated with the thyroid gland |
US7499752B2 (en) | 2005-07-29 | 2009-03-03 | Cyberonics, Inc. | Selective nerve stimulation for the treatment of eating disorders |
US20070025608A1 (en) | 2005-07-29 | 2007-02-01 | Cyberonics, Inc. | Enhancing intrinsic neural activity using a medical device to treat a patient |
US20070027499A1 (en) | 2005-07-29 | 2007-02-01 | Cyberonics, Inc. | Neurostimulation device for treating mood disorders |
US7532935B2 (en) | 2005-07-29 | 2009-05-12 | Cyberonics, Inc. | Selective neurostimulation for treating mood disorders |
EP1910384B1 (en) | 2005-08-04 | 2012-10-10 | Sirtris Pharmaceuticals, Inc. | Imidazo [2,1-b]thiazole derivatives as sirtuin modulating compounds |
US7672727B2 (en) | 2005-08-17 | 2010-03-02 | Enteromedics Inc. | Neural electrode treatment |
US7822486B2 (en) | 2005-08-17 | 2010-10-26 | Enteromedics Inc. | Custom sized neural electrodes |
US7860566B2 (en) | 2005-10-06 | 2010-12-28 | The Cleveland Clinic Foundation | System and method for achieving regular slow ventricular rhythm in response to atrial fibrillation |
US7856264B2 (en) | 2005-10-19 | 2010-12-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for patient interactive neural stimulation and/or chemical substance delivery |
US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
US7620455B2 (en) | 2005-10-25 | 2009-11-17 | Cyberonics, Inc. | Cranial nerve stimulation to treat eating disorders |
US20070100263A1 (en) | 2005-10-27 | 2007-05-03 | Merfeld Daniel M | Mechanical actuator for a vestibular stimulator |
US7957796B2 (en) | 2005-10-28 | 2011-06-07 | Cyberonics, Inc. | Using physiological sensor data with an implantable medical device |
US20070100377A1 (en) | 2005-10-28 | 2007-05-03 | Cyberonics, Inc. | Providing multiple signal modes for a medical device |
US7555344B2 (en) | 2005-10-28 | 2009-06-30 | Cyberonics, Inc. | Selective neurostimulation for treating epilepsy |
EP1948301B8 (en) | 2005-11-10 | 2014-03-12 | ElectroCore LLC | Electrical stimulation treatment of bronchial constriction |
US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
US7630760B2 (en) | 2005-11-21 | 2009-12-08 | Cardiac Pacemakers, Inc. | Neural stimulation therapy system for atherosclerotic plaques |
US7596414B2 (en) | 2005-12-05 | 2009-09-29 | Boston Scientific Neuromodulation Corporation | Cuff electrode arrangement for nerve stimulation and methods of treating disorders |
US7570999B2 (en) | 2005-12-20 | 2009-08-04 | Cardiac Pacemakers, Inc. | Implantable device for treating epilepsy and cardiac rhythm disorders |
US20070150027A1 (en) | 2005-12-22 | 2007-06-28 | Rogers Lesco L | Non-invasive device and method for electrical stimulation of neural tissue |
US9566447B2 (en) | 2005-12-28 | 2017-02-14 | Cardiac Pacemakers, Inc. | Neural stimulation system for reducing atrial proarrhythmia |
US7672728B2 (en) | 2005-12-28 | 2010-03-02 | Cardiac Pacemakers, Inc. | Neural stimulator to treat sleep disordered breathing |
US7610100B2 (en) | 2005-12-30 | 2009-10-27 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating osteoarthritis |
US7467016B2 (en) | 2006-01-27 | 2008-12-16 | Cyberonics, Inc. | Multipolar stimulation electrode with mating structures for gripping targeted tissue |
US20090105782A1 (en) | 2006-03-15 | 2009-04-23 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Vagus nerve stimulation apparatus, and associated methods |
JP5415255B2 (ja) | 2006-03-29 | 2014-02-12 | ディグニティー ヘルス | 病状治療用の脳神経マイクロバースト電気刺激 |
US7974706B2 (en) | 2006-03-30 | 2011-07-05 | Boston Scientific Neuromodulation Corporation | Electrode contact configurations for cuff leads |
US7869885B2 (en) | 2006-04-28 | 2011-01-11 | Cyberonics, Inc | Threshold optimization for tissue stimulation therapy |
US20070255320A1 (en) | 2006-04-28 | 2007-11-01 | Cyberonics, Inc. | Method and apparatus for forming insulated implantable electrodes |
US20070255333A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
US7962220B2 (en) | 2006-04-28 | 2011-06-14 | Cyberonics, Inc. | Compensation reduction in tissue stimulation therapy |
WO2007133718A2 (en) | 2006-05-11 | 2007-11-22 | Neurometrix, Inc | Non-invasive acquisition of large nerve action potentials (naps) with closely spaced surface electrodes and reduced stimulus artifacts |
US8712529B2 (en) | 2010-03-05 | 2014-04-29 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
US8214056B2 (en) | 2006-06-02 | 2012-07-03 | Neurostream Technologies General Partnership | Nerve cuff, method and apparatus for manufacturing same |
DE102006033623B4 (de) | 2006-07-18 | 2010-04-08 | Cerbomed Gmbh | System zur transkutanen Stimulation eines Nervs des menschlichen Körpers |
DE102006036069B4 (de) | 2006-07-18 | 2008-09-04 | Cerbomed Gmbh | Audiologisches Übertragungssystem |
US7996088B2 (en) | 2006-07-26 | 2011-08-09 | Cyberonics, Inc. | Vagus nerve stimulation by electrical signals for controlling cerebellar tremor |
US8868211B2 (en) | 2006-08-15 | 2014-10-21 | Case Western Reserve University | Nerve cuff for implantable electrode |
US7738961B2 (en) | 2006-10-09 | 2010-06-15 | Endostim, Inc. | Method and apparatus for treatment of the gastrointestinal tract |
DE202007019439U1 (de) | 2006-10-13 | 2012-09-12 | Apnex Medical, Inc. | Geräte, Systeme und Methoden zur Behandlung von obstruktiver Schalfapnoe |
US7729760B2 (en) | 2006-10-27 | 2010-06-01 | Cyberonics, Inc. | Patient management system for providing parameter data for an implantable medical device |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US7996092B2 (en) | 2007-01-16 | 2011-08-09 | Ndi Medical, Inc. | Devices, systems, and methods employing a molded nerve cuff electrode |
US7706875B2 (en) | 2007-01-25 | 2010-04-27 | Cyberonics, Inc. | Modulation of drug effects by vagus nerve stimulation |
US20080183246A1 (en) | 2007-01-26 | 2008-07-31 | Cyberonics, Inc. | Method, apparatus and system for guiding a procedure relating to an implantable medical device |
US7974707B2 (en) | 2007-01-26 | 2011-07-05 | Cyberonics, Inc. | Electrode assembly with fibers for a medical device |
US8068918B2 (en) | 2007-03-09 | 2011-11-29 | Enteromedics Inc. | Remote monitoring and control of implantable devices |
CA2680477A1 (en) | 2007-03-13 | 2008-09-18 | The Feinstein Institute For Medical Research | Treatment of inflammation by non-invasive stimulation |
US7819883B2 (en) | 2007-03-13 | 2010-10-26 | Cardiac Pacemakers, Inc. | Method and apparatus for endoscopic access to the vagus nerve |
JP2010524432A (ja) | 2007-03-19 | 2010-07-22 | サートリス ファーマシューティカルズ, インコーポレイテッド | サーチュイン活性のバイオマーカーおよびその使用方法 |
US7974701B2 (en) | 2007-04-27 | 2011-07-05 | Cyberonics, Inc. | Dosing limitation for an implantable medical device |
US20080281365A1 (en) | 2007-05-09 | 2008-11-13 | Tweden Katherine S | Neural signal duty cycle |
CL2008001821A1 (es) | 2007-06-20 | 2009-03-13 | Sirtris Pharmaceuticals Inc | Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras. |
US20090012590A1 (en) | 2007-07-03 | 2009-01-08 | Cyberonics, Inc. | Neural Conductor |
US8391970B2 (en) | 2007-08-27 | 2013-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
WO2009027755A1 (en) | 2007-08-28 | 2009-03-05 | Institut National De La Recherche Agronomique (Inra) | Device and method for reducing weight |
US20090082832A1 (en) | 2007-09-25 | 2009-03-26 | Boston Scientific Neuromodulation Corporation | Thermal Management of Implantable Medical Devices |
US8019419B1 (en) | 2007-09-25 | 2011-09-13 | Dorin Panescu | Methods and apparatus for leadless, battery-less, wireless stimulation of tissue |
US8942798B2 (en) | 2007-10-26 | 2015-01-27 | Cyberonics, Inc. | Alternative operation mode for an implantable medical device based upon lead condition |
US9089707B2 (en) | 2008-07-02 | 2015-07-28 | The Board Of Regents, The University Of Texas System | Systems, methods and devices for paired plasticity |
US8165668B2 (en) | 2007-12-05 | 2012-04-24 | The Invention Science Fund I, Llc | Method for magnetic modulation of neural conduction |
US8195287B2 (en) | 2007-12-05 | 2012-06-05 | The Invention Science Fund I, Llc | Method for electrical modulation of neural conduction |
US8180446B2 (en) | 2007-12-05 | 2012-05-15 | The Invention Science Fund I, Llc | Method and system for cyclical neural modulation based on activity state |
CN201230913Y (zh) | 2007-12-06 | 2009-05-06 | 崔树森 | 自体功能性放大的人工神经导管 |
WO2009097542A2 (en) | 2008-01-30 | 2009-08-06 | Board Of Regents Of The University Of Texas System | Ileal electrical stimulation |
US9014801B2 (en) | 2008-03-19 | 2015-04-21 | The Board Of Trustees Of The University Of Illinois | Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response |
US9211409B2 (en) | 2008-03-31 | 2015-12-15 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of T-cell activity |
EP3047874B1 (en) | 2008-04-04 | 2022-03-09 | ReShape Lifesciences Inc. | Systems for glucose regulation and methods of making such systems |
US20090275997A1 (en) | 2008-05-01 | 2009-11-05 | Michael Allen Faltys | Vagus nerve stimulation electrodes and methods of use |
AU2009316801C1 (en) | 2008-11-18 | 2015-12-24 | Setpoint Medical Corporation | Devices and methods for optimizing electrode placement for anti-inflammatory stimulation |
US20100191304A1 (en) | 2009-01-23 | 2010-07-29 | Scott Timothy L | Implantable Medical Device for Providing Chronic Condition Therapy and Acute Condition Therapy Using Vagus Nerve Stimulation |
US20110054569A1 (en) | 2009-09-01 | 2011-03-03 | Zitnik Ralph J | Prescription pad for treatment of inflammatory disorders |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
WO2010144578A2 (en) | 2009-06-09 | 2010-12-16 | Setpoint Medical Corporation | Nerve cuff with pocket for leadless stimulator |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
-
2012
- 2012-05-09 US US13/467,928 patent/US8788034B2/en active Active
- 2012-05-09 EP EP12781964.7A patent/EP2707094B1/en active Active
- 2012-05-09 WO PCT/US2012/037142 patent/WO2012154865A2/en active Application Filing
- 2012-05-09 CN CN201280031279.9A patent/CN103619405B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080208266A1 (en) * | 2003-07-18 | 2008-08-28 | The Johns Hopkins University | System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation |
CN101528303A (zh) * | 2006-08-29 | 2009-09-09 | 心脏起搏器股份公司 | 用于神经刺激的系统 |
CN101868280A (zh) * | 2007-09-25 | 2010-10-20 | 心脏起搏器股份公司 | 用于心脏病症的神经刺激系统 |
WO2010005482A1 (en) * | 2008-07-08 | 2010-01-14 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
WO2010067360A2 (en) * | 2008-12-09 | 2010-06-17 | Nephera Ltd. | Stimulation of the urinary system |
US20110190849A1 (en) * | 2009-12-23 | 2011-08-04 | Faltys Michael A | Neural stimulation devices and systems for treatment of chronic inflammation |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11766560B2 (en) | 2010-04-01 | 2023-09-26 | Ecole Polytechnique Federale De Lausanne | Device for interacting with neurological tissue and methods of making and using the same |
US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
US11730953B2 (en) | 2014-08-27 | 2023-08-22 | Aleva Neurotherapeutics | Deep brain stimulation lead |
CN108290041A (zh) * | 2015-04-24 | 2018-07-17 | 伽尔伐尼生物电子有限公司 | 神经调节设备 |
CN109069824A (zh) * | 2016-02-02 | 2018-12-21 | 阿莱瓦神经治疗股份有限公司 | 使用深部脑刺激治疗自身免疫疾病 |
US11266830B2 (en) | 2018-03-02 | 2022-03-08 | Aleva Neurotherapeutics | Neurostimulation device |
US11738192B2 (en) | 2018-03-02 | 2023-08-29 | Aleva Neurotherapeutics | Neurostimulation device |
Also Published As
Publication number | Publication date |
---|---|
EP2707094A2 (en) | 2014-03-19 |
EP2707094B1 (en) | 2016-02-03 |
US20120290035A1 (en) | 2012-11-15 |
US8788034B2 (en) | 2014-07-22 |
WO2012154865A3 (en) | 2013-01-31 |
WO2012154865A2 (en) | 2012-11-15 |
CN103619405B (zh) | 2015-11-25 |
EP2707094A4 (en) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103619405B (zh) | 用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活 | |
US10207109B2 (en) | System for combining electrical waveforms into a combined electrical waveform | |
US9211410B2 (en) | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation | |
US9694183B2 (en) | Neuromodulation system and method for providing multiple modulation patterns in a single channel | |
ES2735624T3 (es) | Neuroestimulador implantable para el control de la bradicardia a través de la estimulación del nervio vago | |
AU2014218709B2 (en) | Multi-channel neuromodulation system with means for combining pulse trains | |
US20170216598A1 (en) | Reversing recruitment order by anode intensification | |
US9037261B2 (en) | Method for improving far-field activation in peripheral field nerve stimulation | |
CN108653915A (zh) | 伴随减少能量的多电极刺激治疗 | |
JP2017505195A (ja) | 変調閾値以下治療を患者に行うシステム及び方法 | |
JP2015509817A (ja) | 電圧源を使用したフィールド増強式電流ステアリング | |
WO2020128748A1 (en) | Nerve stimulation system | |
US20140200622A1 (en) | Combination Device and Methods for Treating Congestive Heart Failure and Stroke | |
AU2012253575B2 (en) | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation | |
AU2012253575A1 (en) | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation | |
WO2010027993A3 (en) | Systems for stimulation of the cholinergic anti-inflammatory pathway via a superior vena cava lead |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |